Faculty & Staff at TUC

Mitchell Barnett

Mitchell Barnett

College: COP

Department: Clinical Sciences

Title: Associate Professor

E-Mail: mitchell.barnett@tu.edu

Office: Administration & Faculty 2, Rm. 122

University of Iowa, Iowa City B.S. Pharmacy (Sociology Minor) 1989
University of Iowa, Iowa City M.S Pharmacy Outcomes 1999
University of Iowa, Iowa City PharmD Pharmacy 2004
Touro University, Vallejo Postdoc Psychopharmacotherapy 2005

A) PROFESSIONAL AND GRADUATE COURSES:
Semester Course ID Course Title S* #Units #Hrs** #Students
Spring-98 46:146 Drug Information TA 2 2 100
Spring-00 50:221 Introduction to Patient Research CO 3 6 10
Spring-01 50:221 Introduction to Patient Research CO 3 6 10
Spring-02 50:221 Introduction to Patient Research CO 3 6 10
Spring-03 50:221 Introduction to Patient Research CO 3 6 10
Spring-04 50:221 Introduction to Patient Research CO 3 6 10
Spring-05 50:221 Introduction to Patient Research CO 3 6 10
Spring-06 50:221 Introduction to Patient Research CO 3 6 10
Spring-07 50:221 Introduction to Patient Research CO 3 6 10
Fall-05 PHRM-604 Clinical Sciences CO 5 9 64
Spring-06 PHRM-607 Social and Administrative Sciences CO 3 6 64
Fall-06 PHRM-602 Pharmaceutical Sciences CO 5 6 83
Fall-06 PHRM-604 Clinical Sciences CO 5 6 83
Fall-06 PHRM-611 Social and Administrative Sciences CO 3 6 64
Spring-07 Research Seminar Clinical Sciences CO 0 20 3
Semester Course ID Course Title S* #Units #Hrs** #Students
Fall-07 PHRM-602 Pharmaceutical Sciences CO 5 6 102
Fall-07 PHRM-604 Clinical Sciences CO 5 6 102
Spring-07 PHRM-615 Social and Administrative Sciences CO 3 3 83
Spring-07 PHRM-606 Pharmaceutical Sciences CO 5 9 102
Spring-07 PHRM-610 Pharmaceutical Sciences CO 5 6 83

*Status: TA: Teaching assistant for the class (teaching, small group discussion, and evaluations).
CO: Co-teaching with other professors (responsible for teaching and evaluations for # hours indicated in the “hours” column
** #Hours: Refers to the numbers of hours that I taught in that class for a given semester.
Other Teaching Experience (1991-2002):
• Guest lecturer for Drug Information: 1991-1996, University of Iowa, Iowa City, IA
• Guest lecturer for Health Promotion: 2002, University of Northern Iowa, Cedar Falls, IA
Clinical Teaching Experience:
Adjunct professor: 1990-1998, University of Iowa, Iowa City, IA

My primary research interests involve two seemingly diverse areas of study, namely 1) the use of healthcare claim databases to address clinical research questions, and 2) the use of college of pharmacy educational data to address student assessment questions. The two areas of research are however linked in several ways, which include the ability to maintain and utilize data maintained in different physical locations and formats, the ability to chose and apply appropriate methodological techniques for a given situation, and the ability to recognize limitation of patient/student level data and carefully interpret statistical findings.

With healthcare claims data, I was recently part of a large project estimating rates of monitoring for glucose and lipid dysregulation among new antipsychotic users within an ambulatory Medicaid population. This study demonstrated that antipsychotic users are not receiving appropriate American Diabetic Association guideline monitoring, and highlighted the potential opportunity for community pharmacist to fill such a gap. I am currently pursuing funding options to implement an intervention where community pharmacists would provide glucose and lipid dysregulation monitoring services for a Medicaid population. Another recently completed project utilized a “time of exposure” model, a novel technique in survival analyses to more appropriately estimate the true risk of cerebrovascular events associated with atypical antipsychotic use in dementia patients. I was also recently involved in a pharmacist intervention study looking at the occurrence of adverse events associated with multiple chronic medication use (more than 5 medications) in elderly VA patients.

In the future, I am interested in improving algorithms used to estimate comorbidity and illness severity using pharmacy claims data. Traditionally, severity adjustment measures have used diagnosis data exclusively to estimate the burden of illness. Preliminary studies have shown that adding information derived from pharmacy data may improve the validity of these tools. I feel that this area of research offers an unlimited opportunity to researchers with clinical pharmacy experience and statistical methodology skills.

With student educational data, I was recently part of a project evaluating the findings of the college’s newly developed student formative and summative assessment tool. The innovative measurement tool is known as the “Triple Jump Exam” because it is comprised of three distinct components, a closed book, an open book, and a clinical skills assessment. The Triple Jump Exam was specifically designed to measure ability and provide information regarding student skills not captured in traditional mid-term or final exams. Initial findings were presented to the assessment and curriculum committees, and a peer reviewed manuscript is being finalized. I am also part of an ongoing project to identify student preadmission factors associated with classroom, experiential, formative, and summative exam “success”.

As pharmacy education continues to move away from a traditional classroom environment and towards a clinical or experiential environment, I am interested in developing algorithms useful in identifying student factors related to experiential success. In particular, pharmacy education lags behind medical education in defining and identifying preadmission predictors of clinical success, including experiential program success, licensing exam pass rates for graduates, and percentage rate of graduates becoming board certified. I feel that this area of pharmacy educational research offers a wonderful opportunity for a researcher with teaching experience, measurement theory training, and database skills.

Currently active

Held Lilly Pharmaceuticals, Indianapolis (2005-2007)
P Perry, M Barnett. Risk of Cerebrovascular Events Associated with Antipsychotic Use in Patients with Dementia: A Large Retrospective VA/Medicare Merged Database Analysis. ($11,500/year)

25. Barnett, Mitchell J., VonMuenster, Shannon J., Wehring, Heidi J., Walker, Victor, and Perry, Paul J. Assessment of Monitoring for Glucose and Lipid Dysregulation in Adult Medi-Cal Patients Newly Started on Antipsychotics. Annals of Clinical Psychiatry 2009; 20(X):XX-XX. (in press)

24. Meszaros, Karl, Barnett, Mitchell J., Sasaki-Hill, Debra, Evans, David, McDonald, Karna, and Knapp, Katherine K. Progress Examination for Assessing Students’ Readiness for Advance Pharmacy Practice Experiences. American Journal of Pharmaceutical Education 2009;73(2):Article XX. (in press)

23. Barnett, Mitchell J., Frank, Jessica, Wehring, Heidi J., Newland, Brand, VonMuenster, Shannon, Kumbera, Patty, Halterman, Thomas, and Perry, Paul J. Trends in Medication Therapy Management: The First Decade. Journal of Managed Care Pharmacy 2009; 15(1):18-31.


22. Barnett, Mitchell J., Wehring, Heidi J., and Perry, Paul J. Comparison of Risk of Cerebrovascular Events in an Elderly VA Population with Dementia Between Antipsychotic and Non-Antipsychotic Users. Journal of Clinical Psychopharmacology 2007; 27(6):595-601.

21. Kaboli, Peter J., Shivapour, Daniel S., Henderson, Michael S., Barnett, Mitchell J., Ishani, Areef, and Carter, Barry L. Patient and Provider Perceptions of Hypertension Treatment: Do They Agree? Journal of Clinical Hypertension 2007; 9(6):416-23.

20. Abrams, Thad E., Barnett, Mitchell J., Hoth, Angela B., Schultz, Susan, and Kaboli, Peter J. The Relationship Between Hearing Impairment and Depression in Older Veterans (Letter to the Editor). Journal of the American Geriatrics Society 2006; 54(9):1475.

19. Banerjee, Subhash S., Kerber, Richard E., Barnett, Mitchell J., Banerjee, Pooja, and Jagasia, Dinesh. Warfarin Therapy and Risk of Embolic Events in Elderly Stroke Patients with Aortic Atheroma. Vascular Disease Management 2006; 3(5):339- 44.

18. Barnett, Mitchell J., Langstaff, Jodi E., Kaboli, Peter J., and Perry, Paul J. Comparison of rates of inappropriate medications in a VA and private sector population. Journal of Managed Care Pharmacy 2006; 12(5):362-70.

17. Barnett, Mitchell J., Kaboli, Peter J., Alexander, Bruce J., and Perry, Paul J. Risk of Mortality Associated with Typical Antipsychotics in an Acutely Ill VA Population. Journal of Clinical Psychopharmacology 2006; 26(2):182-87.

16. Perry, Paul J., Argo, Tami R., Barnett, Mitchell J., Liesveld, Jill L., Liskow, Barry, Herna, Jillian M., Trnka, Michael G., Brabson, Mary A. The Association of Alcohol-induced Blackouts and Grayouts to Blood Alcohol Concentrations. Journal of Forensic Sciences 2006; 51(4):896-9.

15. Barnett, Mitchell J., Argo, Tami R., and Perry, Paul J. A Regional Comparison of Developing Diabetes Among VA Patients Exposed to Typical and Atypical Antipsychotics Relative to Corticosteroids and Proton Pump Inhibitors. Annals of Clinical Psychiatry 2006; 18(1):1-7.

14. Ness, Jose J., Hoth, Angela B., Barnett, Mitchell J., Shorr, Ronald I., and Kaboli, Peter J. Anticholinergic Medications and Community-Dwelling Older Veterans: Prevalence of Anticholinergic Symptoms, Symptom Burden, and Adverse Drug Events. The American Journal of Geriatric Pharmacotherapy 2006; 4(1):42-51.

13. Welke, Karl F., Barnett, Mitchell J., Vaughan-Sarrazin, Mary S., and Rosenthal, Gary E. The Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery2005; 80(6):2114-19.

12. Barnett, Mitchell J., Milavetz, Gary, and Kaboli, Peter J. Use of Beta-Blockers in Veterans with Reactive Airway Disease. Pharmacotherapy 2005; 11:1550-59.

11. Kaboli, Peter J., Barnett, Mitchell J., and Rosenthal, Gary E. Associations with Reduced Length of Stay and Costs on an Academic Hospitalist Service American Journal of Managed Care 2004; 10:561-68.

10. Cram, Peter C., Hillis, Steven L., Barnett, Mitchell J., Rosenthal, Gary E. Effects of Weekend Admission and Hospital Teaching Status on In-Hospital Mortality. American Journal of Medicine 2004; 117(3):151-57.

9. Kaboli, Peter J., McClimon, Bradley J., Hoth, Angela B., Barnett, Mitchell J. Assessing the Accuracy of Computerized Medication Histories. American Journal of Managed Care 2004; 10 (part 2):872-77.

8. Zickmund, Susan A., Hillis, Stephen, L. Barnett, Mitchell J., Ippolito, Laura B., and LaBrecque, Douglas R. Difficult Patient or Difficult Disease? Perceived Communicative Problems with Physicians Amongst Patients Diagnosed with Hepatitis C. Hepatology 2004; 39(4):999-1007.

7. Wahls, Terry L., Barnett, Mitchell J., and Rosenthal, Gary E. Predicting Resource Utilization in a Veterans Health Administration Primary Care Population: Comparison of Methods Based on Diagnoses and Medications. Medical Care 2004; 42(2):123-28.

6. Rosenthal, Gary E., Kaboli, Peter J., and Barnett, Mitchell J. Changes in Utilization Patterns in VA and Private Sector Hospitals: Is the VA Closing the Length of Stay Gap? Medical Care 2003; 41(8):882-94.

5. Rosenthal, Gary E,, Kaboli, Peter J., Barnett, Mitchell J., and Sirio, Carl A. Age and the Risk if In-Hospital Death: Insights from a Multi-Hospital Study of Intensive Care Patients. Journal of the American Geriatrics Society [JAGS] 2002; 50:1205-12.

4. Barnett, Mitchell J., Kaboli, Peter J., Sirio, Carl A., and Rosenthal, Gary E. Day of the Week of Intensive Care Admission and Patient Outcomes: A Multi-Site Regional Evaluation. Medical Care 2002; 40(6):530-39.

3. Kaboli, Peter J., Barnett, Mitchell J., Fuehrer, Susan M., and Rosenthal, Gary E. Length of Stay as a Source of Bias in Comparing Performance in VA and Private Sector Facilities: Lessons Learned from a Regional Evaluation of Intensive Care Outcomes. Medical Care 2001; 39: 1014-24.

2. Van Voorhis, Bradley J., Barnett, Mitchell J., Sparks, Amy E.T., Syrop, Craig H., Rosenthal, Gary, E., and Dawson, Jeffrey, E. Effect of the Total Motile Sperm Count on the Efficacy and Cost-Effectiveness of IUI and IVF. Fertility & Sterility 2001; 75(4) 661-68.

1. Taylor, Thomas N., Redford, T., Saag, Kenneth, and Barnett, Mitchell J. Medical Care Use and Expenditures of Persons with Rheumatoid Arthritis in a Nonelderly, Adult Medicaid Population. Arthritis & Rheumatism 1996; 39 (Suppl):S71.


1986-1989 Deans List
1987-1988 Honors Seminar
1988 Rho-Chi Honors Fraternity
1986-1989 University of Iowa Scholar undergraduate research stipend.
1988 Zopf Memorial Scholarship
1989 Charles T Holub Scholarship
1989 McNeil Pharmaceutical Inc. Dean’s Mortar and Pestle Award.
1991-1993 American Foundation of Pharmaceutical Education Fellow.

Last Updated: 5/5/17